IP Library › Granted Patent US 9,371,319
Granted Patent B2
US 9,371,319 · App. 14/004,515 · Granted Jun 21, 2016

Pyrrolopyridineamino derivatives as MPS1 inhibitors

Inventors: Vassilios Bavetsias (Sutton, GB); Butrus Atrash (Sutton, GB); Sebastien Gaston Andre Naud (Sutton, GB); Peter William Sheldrake (Sutton, GB); Julian Blagg (Sutton, GB)
Assignee: CANCER RESEARCH TECHNOLOGY LIMITED
C07D471/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,371,319
App. No.
14/004,515
Granted
Jun 21, 2016
Kind
B2
Abstract

The present invention relates to the use of certain pyrrolopyridineamino derivatives (hereinafter referred to as “PPA derivatives”), particularly 1H-pyrrolo[3,2-c]pyridine-6-amino derivatives, to inhibit the spindle checkpoint function of Monospindle 1 (Mps1—also known as TTK) kinases either directly or indirectly via interaction with the Mps kinase itself. In particular, the present invention relates to PPA derivatives for use as therapeutic agents for the treatment and/or prevention of proliferative diseases, such as cancer. The present invention also relates to processes for the preparation of the PPA derivatives, and pharmaceutical compositions comprising them. Formula (I)

Claims (263)

1. A compound of formula I

wherein:

R 1 is hydrogen, (1-5C)alkyl, (1-5C)fluoroalkyl, (3-8C)cycloalkyl, (3-8C)cycloalkyl-(1-4C)alkyl, aryl, aryl-(1-4C)alkyl, heteroaryl, heteroaryl-(1-4C)alkyl, —S(O) 2 —R a , —C(O)—R a , or —C(O)—O—R a , wherein R a is (1-5C)alkyl, (3-8C)cycloalkyl, (3-8C)cycloalkyl-(1-4C)alkyl, aryl, aryl-(1-4C)alkyl, heteroaryl or heteroaryl-(1-4C)alkyl, and wherein any (1-5C)alkyl, (3-8C)cycloalkyl, (3-8C)cycloalkyl-(1-4C)alkyl, aryl, aryl-(1-4C)alkyl, heteroaryl, heteroaryl-(1-4C)alkyl group present in a R 1 substituent group is optionally substituted by methyl, trifluoromethyl, methoxy, trifluoromethoxy, halo, cyano, nitro, hydroxy, mercapto, amino, carboxy, carbamoyl, or sulphamoyl;

R 2 is an aryl, aryl(1-2C)alkyl, 5- or 6-membered heteroaryl or a 5- or 6-membered heteroaryl(1 -2C)alkyl,

wherein R 2 is optionally substituted by one or more substituents selected from halogeno, trifluoromethyl, trifluoromethoxy, cyano, nitro, hydroxy, mercapto, amino, carboxy, carbamoyl, sulphamoyl,

or a group of the formula:

L-L 0 -R b

wherein

L is absent or a linker group of the formula —[CR g R h ] n — in which n is an integer selected from 1, 2, 3 or 4, and R g and R h are each independently selected from hydrogen or (1-2C)alkyl;

L 0 is absent or is selected from O, S, SO, SO 2 , N(R c ), C(O), C(O)O, OC(O), CH(OR c ),)C(O)N(R c ), N(R c )C(O), N(R c )C(O)N(R d ), SO 2 N(R c ), or N(R c )SO 2 , wherein R c and R d are each independently selected from hydrogen or (1-2C)alkyl; and

R b is (1-4C)alkyl, aryl, aryl-(1-4C)alkyl, (3-6C)cycloalkyl, (3-6C)cycloalkyl-(1-4C)alkyl, heteroaryl, heteroaryl-(1 -4C)alkyl, heterocyclyl, or heterocyclyl-(1-4C)alkyl;

and wherein R b is optionally further substituted by one or more substituents independently selected from oxo, halogeno, cyano, nitro, hydroxy, NR e R f , (1-5C)alkyl, (1-5C)alkoxy, (1-5C)alkanoyl, (1-5C)sulphonyl or aryl; and wherein R e and R f are each independently selected from hydrogen or (1-4C)alkyl or (3-6C)cycloalkyl-(1-4C)alkyl; or R e and R f can be linked such that, together with the nitrogen atom to which they are attached, they form a 4-7 membered heterocyclic, heteroaryl or carbocyclic ring;

R 3 is H, (1-3C)alkyl, halogeno or CF 3 ;

R 4 is cyano, (1-3C)alkyl, (1-3C)fluoroalkyl, (1-3C)alkoxy, (1-3C)perfluoroalkoxy, halo, (1-3C)alkanoyl, C(O)NR i R j , or S(O) 2 NR i R j ; wherein R i and R j are each independently selected from H or (1-3C)alkyl;

X is CH or CR 5 ;

W, Y and Z are each independently selected from N, CH, or CR 5 ;

R 5 is halogeno, trifluoromethyl, trifluoromethoxy, cyano, nitro, hydroxy, mercapto, amino, carboxy, carbamoyl, sulphamoyl, ureido, (1-6C)alkyl, (2-6C)alkenyl, (2-6C)alkynyl,

or R 5 is a group of the formula:

-L 1 -L 2 -R 7

wherein

L 1 is absent or a linker group of the formula —[CR 8 R 9 ] n — in which n is an integer selected from 1, 2, 3 or 4, and R 8 and R 9 are each independently selected from hydrogen or (1-2C)alkyl;

L 2 is absent or is selected from O, S, SO, SO 2 , N(R 10 ), C(O), C(O)O, OC(O), CH(OR 10 ), C(O)N(R 10 ), N(R 10 )C(O), N(R 10 )C(O)N(R 11 ), S(O) 2 N(R 10 ), or N(R 13 )SO 2 , wherein R 10 and R 11 are each independently selected from hydrogen or (1-2C)alkyl; and

R 7 is (1-6C)alkyl, aryl, aryl-(1-6C)alkyl, (3-6C)cycloalkyl, (3-6C)cycloalkyl-(1 -6C)alkyl, heteroaryl, heteroaryl-(1 -6C)alkyl, heterocyclyl, heterocyclyl-(1 -6C)alkyl,

and wherein R 7 is optionally further substituted by one or more substituents independently selected from hydrogen, oxo, halogeno, cyano, nitro, hydroxy, NR 12 R 13 , (1-4C)alkoxy, (1-5C)alkyl, (3-8C)cycloalkyl, (3-8C)cycloalkyl-(1-5C)alkyl, aryl, aryl-(1-5C)alkyl, (1-5C)alkanoyl, (1-5C)alkylsulphonyl, heterocyclyl, heterocyclyl-(1 -5C)alkyl, heteroaryl, heteroaryl-(1-5C)alkyl, CONR 12 R 13 and SO 2 NR 12 R 13 ;

R 12 and R 13 are each independently selected from hydrogen or (1-2C)alkyl; or R 12 and R 13 can be linked such that, together with the nitrogen atom to which they are attached, they form a 4-7 membered heterocyclic or heteroaryl ring;

or either W and Z, W and Y or Z and X are both CR 5 and the R 5 groups on the adjacent carbon atoms are linked such that, together with the carbon atoms to which they are attached, they form a fused 4-7 membered heterocyclic, heteroaryl or carbocyclic ring;

or a pharmaceutically acceptable salt or solvate thereof.

2. A compound according to claim 1 , wherein R 1 is hydrogen, (1-5C)alkyl, (1-5C)fluoroalkyl, (3-8C)cycloalkyl, (3-8C)cycloalkyl-(1-4C)alkyl, aryl, aryl-(1-4C)alkyl, heteroaryl, heteroaryl-(1-4C)alkyl, —S(O) 2 —R a , —C(O)—R a , or —C(O)—O—R a , wherein R a is (1-5C)alkyl, (3-8C)cycloalkyl, (3-8C)cycloalkyl-(1-2C)alkyl, aryl, aryl-(1-2C)alkyl, heteroaryl or heteroaryl-(1-2C)alkyl, and wherein any (1-5C)alkyl, (3-8C)cycloalkyl, (3-8C)cycloalkyl-(12C)alkyl, aryl, aryl-(1-2C)alkyl, heteroaryl, heteroaryl-(1-2C)alkyl group present in a R 1 substituent group is optionally substituted by methyl, trifluoromethyl, methoxy, trifluoromethoxy, halo, cyano, hydroxy or amino.

3. A compound according to claim 1 , wherein R 1 is hydrogen or —C(O)—O—R a , wherein R a is (1-5C)alkyl, (3-6C)cycloalkyl, (3-6C)cycloalkyl-(1-2C)alkyl, and wherein any (1-5C)alkyl, (3-8C)cycloalkyl, (3-8C)cycloalkyl-(1-2C)alkyl group is optionally substituted by methyl, trifluoromethyl, methoxy, trifluoromethoxy, halo, cyano, hydroxy or amino.

4. A compound according to claim 1 , wherein R 1 is hydrogen or —C(O)—O—R a , wherein R a is (1-5C)alkyl, (3-6C)cycloalkyl, (3-6C)cycloalkyl-(1-2C)alkyl.

5. A compound according to claim 1 , wherein R 2 is an aryl or a 5- or 6-membered heteroaryl, wherein R 2 is optionally substituted by one or more substituents selected from trifluoromethyl, cyano, amino, or a group of the formula:

L-L 0 -R b

wherein

L is absent or a linker group of the formula —[CR g R h ] n — in which n is 1 or 2, and R g and R h are hydrogen;

L 0 is absent or is selected from O, SO 2 , N(R c ), C(O)O, C(O)N(R c ), or SO 2 N(R c ), wherein R c is selected from hydrogen or (1-2C)alkyl; and

R b is (1-4C)alkyl, heteroaryl, or heterocyclyl-(1-4C)alkyl;

and wherein R b is optionally further substituted by one or more substituents independently selected from oxo, and NR e R f ; and wherein R e and R f can be linked such that, together with the nitrogen atom to which they are attached, they form a 4-7 membered heterocyclic ring.

6. A compound according to claim 5 , wherein R 2 is a 5-membered heteroaryl having one of the following structures:

wherein R 14 is H, methyl or trifluoromethyl.

7. A compound according to claim 1 , wherein R 3 is H or chloro.

8. A compound according to claim 7 , wherein R 3 is H.

9. A compound according to claim 1 , wherein R 4 is cyano, (1-3C)alkyl, (1-3C)perfluoroalkyl, (1-3C)alkoxy, (1-3C)perfluoroalkoxy or halo.

10. A compound according to claim 9 , wherein R 4 is chloro of methoxy.

11. A compound according to claim 1 , wherein X is CH, and W, Y or Z are selected from N, CH or CR 5 , with the proviso that one of W, Y and Z is CR 5 .

12. A compound according to claim 1 , wherein R 5 is halogeno, trifluoromethyl, cyano, hydroxy, or R 5 is a group of formula:

-L 1 -L 2 -R 7

wherein

L 1 is absent or a linker group of the formula —[CR 8 R 9 ] n — in which n is 1, and R 8 and R 9 are each independently selected from hydrogen or (1-2C)alkyl;

L 2 is absent or is selected from O, SO 2 , N(R 10 ), C(O), C(O)N(R 10 ), N(R 10 )C(O), or S(O) 2 N(R 10 ), or N(R 13 )SO 2 , wherein R 10 is selected from hydrogen or (1-2C)alkyl; and

R 7 is (1-6C)alkyl, aryl, heteroaryl, heteroaryl-(1-6C)alkyl, heterocyclyl, or heterocyclyl-(1-6C)alkyl, wherein R 7 is optionally further substituted by one or more substituents independently selected from oxo, halogeno, cyano, NR 12 R 13 , (1-4C)alkoxy, (1-5C)alkyl, or (1-5C)alkanoyl; and

wherein R 12 , and R 13 are each independently selected from hydrogen or (1-2C)alkyl; or

R 12 and R 13 can be linked such that, together with the nitrogen atom to which they are attached, they form a 4-7 membered heterocyclic ring.

13. A compound according to claim 12 , wherein R 5 is selected from one of the following structures:

wherein R 6 is independently selected from the group including hydrogen, (1-5C)alkyl, (3-8C)cycloalkyl, (3-8C)cycloalkyl-(1-5C)alkyl, aryl, aryl-(1-5C)alkyl, (1-5C)alkanoyl, (1-5C)sulphonyl.

14. A compound selected from any one of the following:

isopropyl 6-((4-methoxy-2-(1-methyl-1H-pyrazol-4-yl)pyrimidin-5-yl)amino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

isopropyl 6-((4-(1,2-dimethyl-1H-imidazol-5-yl)phenyl)amino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

isopropyl 6-(4-(1,3-dimethyl-1H-pyrazol-4-yl)-2-methoxyphenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

N-(2-chloro-5-(1-methyl-1H-pyrazol-4-yl)phenyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridin-6-amine;

tert-butyl 6-((2-chloro-5-(1-methyl-1H-pyrazol-4-yl)phenyl)amino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

N-(2-chloro-4-(1,2-dimethyl-1H-imidazol-5-yl)phenyl)-2-(oxazol-5-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

tert-butyl 6-(2-chloro-4-(1,2-dimethyl-1H-imidazol-5-yl)phenylamino)-2-(oxazol-5-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

isopropyl 6-(2-chloro-4-(1,2-dimethyl-1H-imidazol-5-yl)phenylamino)-2-(oxazol-5-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

isopropyl 6-(2-methoxy-4-(1-methyl-1H-pyrazol-4-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

isopropyl 6-((2-chloro-5-(1-methyl-1H-pyrazol-4-yl)phenyl)amino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

N-(2-chloro-4-(1,2-dimethyl-1H-imidazol-5-yl)phenyl)-1-(2-methoxyethyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

tert-butyl 6-(2-chloro-4-(1,4-dimethyl-1H-imidazol-5-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

N-(2-chloro-4-(1,2-dimethyl-1H-imidazol-5-yl)phenyl)-1-(cyclopropylmethyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

N-(2-chloro-4-(1-methyl-1H-imidazol-5-yl)phenyl)-2-(oxazol-5-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

tert-butyl 6-((2-chloro-4-(3,3-difluoroazetidine-1-carbonyl)phenyl)amino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

(3-chloro-4-((2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-yl)amino)phenyl)(3 ,3-difluoroazetidin-1-yl)methanone;

propyl-6-(2-chloro-4-(1,2-dimethyl-1H-imidazol-5-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

ethyl-6-(2-chloro-4-(1,2-dimethyl-1H-imidazol-5-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

methyl-6-(2-chloro-4-(1,2-dimethyl-1H-imidazol-5-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

isopropyl 6-(4-(1,2-dimethyl-1H-imidazol-5-yl)-2-methoxyphenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl 6-(2-chloro-4-(oxazol-5-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridine-1-carboxylate;

tert-butyl 6-(2-chloro-4-(thiazol-5-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridine-1-carboxylate;

tert-butyl 6-(2-chloro-4-(5-methylisoxazol-4-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl 6-((2-chloro-4-(pyrazin-2-yl)phenyl)amino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridine-1-carboxylate;

cyclobutyl 6-(2-chloro-4-(1,2-dimethyl-1H-imidazol-5-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

cyclopentyl 6-(2-chloro-4-(1,2-dimethyl-1H-imidazol-5-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

isopropyl 6-(2-chloro-4-(1,2-dimethyl-1H-imidazol-5-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl 6-(2-chloro-4-(6-methylpyridin-3-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl 6-(2-chloro-4-(1-methyl-1H-imidazol-2-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl 6-(2-chloro-4-(1,3-dimethyl-1H-pyrazol-4-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl 6-(2-chloro-4-(1,5-dimethyl-1H-pyrazol-4-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl 6-(2-chloro-4-(pyridin-3-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridine-1-carboxylate;

tert-butyl 6-(2-chloro-4-(4-methyl-4H-1,2,4-triazol-3-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl 6-((2-chloro-4-(pyrimidin-5-yl)phenyl)amino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl-6-(2-chloro-4-(6-methoxypyridin-3-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

cyclobutyl-6-(2-chloro-4-(1-methyl-1H-imidazol-5-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

cyclobutyl-6-(2-chloro-4-(dimethylcarbamoyl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

N-(2-chloro-4-(1-methyl-1H-imidazol-5-yl)phenyl)-1-cyclopentyl-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

isopropyl 6-(2-chloro-4-(1-methyl-1H-imidazol-5-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl 6-(2-chloro-4-(1-methyl-1H-imidazol-5-yl)phenylamino)-2-(oxazol-5-yl)-1H-pyrrolo [3,2-c]pyridine-1-carboxylate;

cyclopentyl 6-((2-chloro-4-(1-methyl-1H-imidazol-5-yl)phenyl)amino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl 6-((4-(azetidine-1-carbonyl)-2-chlorophenyl)amino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

N-(2-chloro-4-(1,2-dimethyl-1H-imidazol-5-yl)phenyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

tert-butyl 6-(2-chloro-4-(1,2-dimethyl-1H-imidazol-5-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

3-chloro-N,N-dimethyl-4-(2-(1-methyl-1H-pyrazol-4-yl)-1-(5-methylpyridin-2-yl)-1H-pyrrolo [3,2-c]pyridin-6-ylamino)benzamide;

3-chloro-N,N-dimethyl-4-(2-(1-methyl-1H-pyrazol-4-yl)-1-(pyrimidin-2-yl)-1H-pyrrolo [3,2-c]pyridin-6-ylamino)benzamide;

3-chloro-N,N-dimethyl-4-(2-(1-methyl-1H-pyrazol-4-yl)-1-(pyridin-2-yl)-1H-pyrrolo [3,2-c]pyridin-6-ylamino)benzamide;

N-(2-chloro-4-(2-methoxypyridin-4-yl)phenyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridin-6-amine;

tert-butyl 6-(2-chloro-4-(2-methoxypyridin-4-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

N-(2-chloro-4-(2,4-dimethylthiazol-5-yl)phenyl)-2(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridin-6-amine;

tert-butyl 6-(2-chloro-4-(2,4-dimethylthiazol-5-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

N-(2-chloro-4-(1-methyl-1H-pyrazol-5-yl)phenyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridin-6-amine;

tert-butyl 6-(2-chloro-4-(1-methyl-1H-pyrazol-5-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

isopropyl 6-(2-chloro-4-(dimethylcarbamoyl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

isopropyl 6-(2-chloro-4-(1-methyl-1H-pyrazol-4-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

N-(2-chloro-4-(1-methyl-1H-imidazol-5-yl)phenyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridin-6-amine;

N-(2-chloro-4-(1-methyl-1H-pyrazol-3-yl)phenyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridin-6-amine;

(3-chloro-4-(2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)phenyl)(4-(dimethylamino)piperidin-1-yl)methanone;

tert-butyl-6-(2-chloro-4-(4-(dimethylamino)piperidine-1-carbonyl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

cyclopentyl 6-(2-chloro-4-(1-methyl-1H-pyrazol-4-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

(3-chloro-4-(2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)phenyl)(4-methoxypiperidin-1-yl)methanone;

tert-butyl 6-(2-chloro-4-(4-methoxypiperidine-1-carbonyl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl 6-(2-chloro-4-(1-methyl-1H-imidazol-5-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl 6-(2-chloro-4-(1-methyl-1H-pyrazol-3-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

(3-chloro-4-(2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)phenyl)(4-methylpiperazin-1-yl)methanone;

tert-butyl 6-(2-chloro-4-(4-methylpiperazine-1-carbonyl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

(3-chloro-4-(3-chloro-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)phenyl)(S,S-dioxo-thiomorpholino)methanone;

(3-chloro-4-(3-chloro-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)phenyl)(3-methoxyazetidin-1-yl)methanone;

(3-chloro-4-(2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)phenyl)(pyrrolidin-1-yl)methanone;

tert-butyl 6-(2-chloro-4-(pyrrolidine-1-carbonyl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

3-chloro-N-ethyl-N-methyl-4-(2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)benzamide;

tert-butyl 6-(2-chloro-4-(ethyl(methyl)carbamoyl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

(3-chloro-4-(2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)phenyl)(S,S-dioxo-thiomorpholino)methanone;

tert-butyl 6-(2-chloro-4-(S,S-dioxo-thiomorpholine-4-carbonyl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

N-(2-chlorophenyl)-1-(cyclohexylmethyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridin-6-amine;

3-chloro-N-(2-chloro-4-(1-methyl-1H-pyrazol-4-yl)phenyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

3-chloro-N-(2-chlorophenyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

N-(2-chlorophenyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

N-(2-chlorophenyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

(3-chloro-4-(2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)phenyl)(3-methoxyazetidin-1-yl)methanone;

tert-butyl 6-(2-chloro-4-(3-methoxyazetidine-1-carbonyl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl 6-(2-chloro-4-(1-methyl-1H-pyrazol-4-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl 6-(2-chlorophenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

3-chloro-4-(1-isopropyl-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)-N,N-dimethylbenzamide;

3-chloro-4-(1-cyclopentyl-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)-N,N-dimethylbenzamide;

3-chloro-4-(3-chloro-1-(cyclopentylmethyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridin-6-ylamino)-N,N-dimethylbenzamide;

3-chloro-4-(3-chloro-1-(cyclopropylmethyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridin-6-ylamino)-N,N-dimethylbenzamide;

3,5-dichloro-N,N-dimethyl-4-(2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)benzamide;

tert-butyl 6-(4-(dimethylcarbamoyl)-2-(trifluoromethoxy)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl 6-(2,6-dichloro-4-(dimethylcarbamoyl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

3-chloro-4-(1-(cyclopropylmethyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)-N,N-dimethylbenzamide;

cyclopentyl 6-(2-chloro-4-(dimethylcarbamoyl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

3-chloro-4-(1-(cyclohexylmethyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)-N,N-dimethylbenzamide;

3-chloro-4-(1-(4-fluorobenzyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)-N,N-dimethylbenzamide;

3-chloro-4-(1-(cyclopentylsulfonyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)-N,N-dimethylbenzamide;

3-chloro-4-(3-chloro-2-(oxazol-5-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)-N,N-dimethylbenzamide;

tert-butyl 6-(2-methoxyphenylamino)-2-(oxazol-5-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

3-chloro-N,N-dimethyl-4-((2-(1-methyl-1H-pyrazol-4-yl)-1((5-methylisoxazol-3-yl)methyl)-1H-pyrrolo[3,2-c]pyridin-6-yl)amino)benzamide;

(3-methoxy-4-(2-(oxazol-5-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)phenyl)(3-methoxyazetidin-1-yl)methanone;

tert-butyl 6-(2-methoxy-4-(3-methoxyazetidine-1-carbonyl)phenylamino)-2-(oxazol-5-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

3-chloro-N,N-dimethyl-4-(2-(oxazol-5-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)benzamide;

tert-butyl 6-(2-chloro-4-(dimethylcarbamoyl)phenylamino)-2-(oxazol-5-yl)-1H-pyrrolo [3,2-c]pyridine-1-carboxylate;

3-chloro-N-(2-chloro-4-(methylsulfonyl)phenyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridin-6-amine;

2-(3-(2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)phenoxy)acetonitrile;

tert-butyl 6-(3-(cyanomethoxy)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridine-1-carboxylate;

tert-butyl 3-chloro-6-(2-chloro-4-(dimethylcarbamoyl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

3-chloro-4-(1-(cyclopentylmethyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)-N,N-dimethylbenzamide;

N-(4-(aminomethyl)-2-methoxyphenyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

N-(4-((dimethylamino)methyl)-2-methoxyphenyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridin-6-amine;

tert-butyl 6-(4-((dimethylamino)methyl)-2-methoxyphenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

N-(2-methoxy-4-((methylamino)methyl)phenyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridin-6-amine;

tert-butyl 6-(4-((tert-butoxycarbonyl(methyl)amino)methyl)-2-methoxyphenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

N-(2-methoxy-4-(pyrrolidin-1-ylmethyl)phenyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridin-6-amine;

tert-butyl 6-(2-methoxy-4-(pyrrolidin-1-ylmethyl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl 6-((2-cyanophenyl)amino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl 6-((2-chloro-4-(methylsulfonyl)phenyl)amino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

(3-methoxy-4-(2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)phenyl)(3-methoxyazetidin-1-yl)methanone;

3-methoxy-N-(2-methoxyethyl)-4-(2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)benzamide;

(3-methoxy-4-(2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)phenyl)(morpholino)methanone;

tert-butyl 6-(2-methoxy-4-(3-methoxyazetidine-1-carbonyl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl 6-(2-methoxy-4-(2-methoxyethylcarbamoyl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl 6-(2-methoxy-4-(morpholine-4-carbonyl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

N-(2-methoxyphenyl)-2-(oxazol-5-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

tert-butyl 6-(2-chloro-4-(dimethylcarbamoyl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl 6-(2-acetylphenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

3-chloro-N,N-dimethyl-4-(2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)benzenesulfonamide;

tert-butyl 6-(2-chloro-4-(N,N-dimethylsulfamoyl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl 6-(2-chloro-4-(2-oxopyrrolidin-1-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

2-(4-(6-(2,4-dimethoxyphenylamino)-1H-pyrrolo[3,2-c]pyridin-2-yl)-1H-pyrazol-1-yl)-N,N-dimethylacetamide;

3-chloro-4-(3-chloro-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)-N,N-dimethylbenzamide;

N-(2-methoxy-4-(thiomorpholinomethyl)phenyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridin-6-amine-S,S-dioxide;

(3-methoxy-4-(2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)phenyl)(thiomorpholino)methanone-S,S-dioxide;

N-(2-chloro-4-(methylsulfonyl)phenyl)-2-(1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

4-methoxy-N,N-dimethyl-3-(2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)benzamide;

N,N-dimethyl-4-(2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)-3-(trifluoromethoxy)benzamide

3-chloro-N-methyl-4-(2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)benzamide;

3-methoxy-N-methyl-4-(2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)benzamide;

N-(2-fluoro-4-methoxyphenyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

N-(2-methoxy-4-(trifluoromethyl)phenyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

N-(2-chloro-4-(difluoromethoxy)phenyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

N-(2-methoxypyridin-3-yl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

N-(4-fluoro-2-methoxyphenyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

N-(2-methoxyphenyl)-2-(1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

N-(2-chloro-4-(methylsulfonyl)phenyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

3-methoxy-4-((2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-yl)amino)-N-( 1-methylpiperidin-4-yl)benzamide;

N-(2-chloro-4-fluorophenyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

N-(2-chloro-4-(1H-1,2,4-triazol-1-yl)phenyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridin-6-amine;

2-(1-(difluoromethyl)-1H-pyrazol-4-yl)-N-(2-methoxyphenyl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

3-methoxy-N,N-dimethyl-4-(2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)benzamide;

3-chloro-N,N-dimethyl-4-(2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)benzamide;

N-(2,4-dimethoxyphenyl)-2-(1((5-methylisoxazol-3-yl)methyl)-1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridin-6-amine;

1-(4-(4-(2-(1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)phenyl)piperazin-1-yl)ethanone;

N-(4-(morpholinomethyl)phenyl)-2-(1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

N-(4-(2-methoxyethoxy)phenyl)-2-(1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

N-(4-((1H-pyrazol-1-yl)methyl)phenyl)-2-(1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

N-(4-(2-morpholinoethoxy)phenyl)-2-(1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

2-(1H-pyrazol-4-yl)-N-(4-(thiomorpholinomethyl)phenyl)-1H-pyrrolo[3,2-c]pyridin-6-amine-S,S-dioxide;

4-(2-(1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)benzonitrile;

N-(3 ,4-dimethoxyphenyl)-1-methyl-2-(1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

N-(2-methoxyphenyl)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

4-(2-(1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)-N,N-dimethylbenzenesulfonamide;

N-(2-ethoxyphenyl)-2-(1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

4-(2-(1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-ylamino)-N,N-dimethylbenzamide;

2-(1H-pyrazol-4-yl)-N-(2-(trifluoromethyl)phenyl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

N-(2-chloro-4-methoxyphenyl)-2-(1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

N-(2,4-dimethoxyphenyl)-2-(1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

N-(2-methoxyphenyl)-2-(1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

N-(2-methoxy-4-(1-methylpiperidin-4-yloxy)phenyl)-2-(1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridin-6-amine;

N-(4-methoxyphenyl)-2-(1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

N-(5-fluoropyridin-2-yl)-2-(1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

N-(4-fluorophenyl)-1-(methylsulfonyl)-2-(1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

tert-butyl 2-(1-(tert-butoxycarbonyl)-1H-pyrazol-4-yl)-6-(p-tolylamino)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

2-(1H-pyrazol-4-yl)-N-(4-(trifluoromethyl)phenyl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

N-(4-fluorophenyl)-2-(1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

N-(3 ,4-dimethoxyphenyl)-2-(1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine;

tert-butyl-6-(2-chloro-4-(2-oxopyrrolidin-1-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl 6-(2-methoxy-4-(thiomorpholinomethyl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate-S,S-dioxide;

tert-butyl 6-(2-methoxy-4-(thiomorpholine-4-carbonyl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate-S,S-dioxide;

tert-butyl-6-(2-chloro-4-(methylcarbamoyl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl-6-(2-methoxy-4-(methylcarbamoyl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl 6-((2-fluoro-4-methoxyphenyl)amino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridine-1-carboxylate;

tert-butyl 6-((2-methoxy-4-(trifluoromethyl)phenyl)amino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl-6-(2-chloro-4-(difluoromethoxy)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl 6-(2-methoxypyridin-3-ylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridine-1-carboxylate;

tert-butyl 6-((4-fluoro-2-methoxyphenyl)amino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridine-1-carboxylate;

tert-butyl 6-(2-methoxyphenylamino)-2-(1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridine-1-carboxylate;

tert-butyl-6-(2-chloro-4-(methylsulfonyl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl 6-(2-methoxy-4-(1-methylpiperidin-4-ylcarbamoyl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl-6-(2-chloro-4-fluorophenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo [3,2-c]pyridine-1-carboxylate;

tert-butyl-6-(2-chloro-4-(1H-1,2,4-triazol-1-yl)phenylamino)-2-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate;

tert-butyl 2-(1-(difluoromethyl)-1H-pyrazol-4-yl)-6-(2-methoxyphenylamino)-1H-pyrrolo [3,2-c]pyridine-1-carboxylate;

or a pharmaceutically acceptable salt or solvate thereof.

15. A pharmaceutical composition comprising (a) a compound, or a pharmaceutically acceptable salt or solvate thereof, as defined in claim 1 , and (b) a pharmaceutically acceptable diluent or carrier.

16. A method of treating a proliferative disorder in a patient in need of such treatment, said method comprising administering to said patient a therapeutically effective amount of a compound of formula I

wherein:

R 1 , R 2 , R 3 , W, X, Y, and Z is are as defined in claim 1 and

R 4 is H, cyano, (1-3C)alkyl, (1-3C)fluoroalkyl, (1-3C)alkoxy, (1-3C)perfluoroalkoxy, halo, (1-3C)alkanoyl, C(O)NR i R j , or S(O) 2 NR i R j ; wherein R i and R j are each independently selected from H or (1-3C)alkyl;

or a pharmaceutically acceptable salt or solvate thereof.

17. The method of claim 16 , wherein the proliferative disorder is a cancer.

18. A method of synthesizing a compound of the formula I, or a pharmaceutically acceptable salt or solvate thereof, as claimed in claim 1 , the method comprising:

a) reacting an intermediate of formula A:

wherein R 1 , R 2 , and R 3 each have any one of the meanings as defined in claim 1 , and LG A is a suitable leaving group;

with an intermediate of formula B:

wherein R 4 , X, Z, W, and Y have any one of the definitions set out in claim 1 ; and

b) optionally thereafter, and if necessary:

i) removing any protecting groups present;

ii) converting the compound formula I into another compound of formula I; and/or

iii) forming a pharmaceutically acceptable salt or solvate thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2014
From: BAVETSIAS, VASSILIOS; ATRASH, BUTRUS; NAUD, SEBASTIEN GASTON ANDRE; SHELDRAKE, PETER WILLIAM; BLAGG, JULIAN
To: INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE)
Reel/Frame 033476/0498 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2014
From: INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE)
To: CANCER RESEARCH TECHNOLOGY LIMITED
Reel/Frame 033476/0657 →
Priority Claims (1)
GB 1104267.8 · Mar 14, 2011 · national
Continuity (1)
Related Publication 20130345181A1 · Dec 26, 2013